Crinetics Pharmaceuticals Inc (CRNX)

03:45 AM

Risk Hedge: Is Crinetics Pharmaceuticals Inc exposed to currency risks2026 Market WrapUp & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

03:45 AM

Apr 05, 2026

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN

Apr 05, 2026

Apr 05, 2026

Aberdeen Group plc Buys 334,584 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - marketbeat.com

Apr 05, 2026

Apr 04, 2026

Price performance - Yahoo Finance Australia

Apr 04, 2026

Apr 02, 2026

Crinetics Pharmaceuticals Inc (6Z4.DU) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

Price-Driven Insight from (CRNX) for Rule-Based Strategy - Stock Traders Daily

Apr 02, 2026

Apr 02, 2026

CRNX Stock Price, Quote & Chart | CRINETICS PHARMACEUTICALS IN (NASDAQ:CRNX) - ChartMill

Apr 02, 2026

Apr 01, 2026

Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More - AOL.com

Apr 01, 2026

Mar 31, 2026

Crinetics Pharmaceuticals Director Sells Shares - intellectia.ai

Mar 31, 2026

Mar 30, 2026

Crinetics Pharmaceuticals Inc. (CRNX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Mar 30, 2026

Mar 29, 2026

CRNX PE Ratio & Valuation, Is CRNX Overvalued - Intellectia AI

Mar 29, 2026

Mar 29, 2026

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Analysts - marketbeat.com

Mar 29, 2026

Mar 28, 2026

Crinetics Pharma Director Stock SaleMarch 2026 Transaction DetailsNews and Statistics - IndexBox

Mar 28, 2026

Mar 28, 2026

Crinetics Pharma COO to step down - MSN

Mar 28, 2026

Mar 28, 2026

Crinetics Pharmaceuticals (NASDAQ:CRNX) Rating Lowered to "Sell" at Wall Street Zen - marketbeat.com

Mar 28, 2026

Mar 26, 2026

Crinetics submits application for acromegaly drug in Brazil By Investing.com - Investing.com Australia

Mar 26, 2026

Mar 26, 2026

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify (Paltusotine) in Acromegaly - Bitget

Mar 26, 2026

Mar 26, 2026

Vanguard disaggregates holdings; Crinetics (CRNX) parent reports 0 shares - Stock Titan

Mar 26, 2026

Mar 26, 2026

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly - The Manila Times

Mar 26, 2026

Mar 26, 2026

Crinetics submits application for acromegaly drug in Brazil - Investing.com

Mar 26, 2026

Mar 26, 2026

Crinetics Pharmaceuticals Announces Submission of Marketing - GlobeNewswire

Mar 26, 2026

Mar 25, 2026

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha

Mar 25, 2026

Mar 23, 2026

Crinetics Pharmaceuticals (CRNX) Executive Resignation Announced - GuruFocus

Mar 23, 2026

Mar 23, 2026

Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Price Down 4.3%Here's Why - MarketBeat

Mar 23, 2026

Mar 23, 2026

Crinetics Pharmaceuticals, Inc. Announces Resignation of Jeff Knight as Chief Development and Operating Officer, Effective on or About April 10, 2026 - MarketScreener

Mar 23, 2026

Mar 23, 2026

Crinetics Pharmaceuticals, Inc. Files Form 8-K with SEC: Company Details, Stock Info, and Compliance Data (March 2026) - Minichart

Mar 23, 2026

Mar 23, 2026

Crinetics Pharmaceuticals chief development and operating officer to resign By Investing.com - Investing.com South Africa

Mar 23, 2026

Mar 23, 2026

Crinetics Pharmaceuticals chief development and operating officer to resign - Investing.com

Mar 23, 2026

Mar 23, 2026

Crinetics' Jeff Knight to Resign as Chief Development and Operating Officer - TradingView

Mar 23, 2026

Mar 23, 2026

Crinetics (NASDAQ: CRNX) COO-level executive Jeff Knight to resign by April 10, 2026 - Stock Titan

Mar 23, 2026

Mar 23, 2026

Q4 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

Mar 23, 2026

Mar 23, 2026

Q2 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

Mar 23, 2026

Mar 23, 2026

Q1 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

Mar 23, 2026

Mar 23, 2026

Q3 2025 Crinetics Pharmaceuticals Inc Earnings Call Transcript - gurufocus.com

Mar 23, 2026

Mar 21, 2026

Stock Market Recap: Is Crinetics Pharmaceuticals Inc a stock for growth or value investorsTake Profit & Daily Stock Trend Watchlist - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Merger Talk: Whats the beta of Crinetics Pharmaceuticals Inc stockWeekly Market Report & Technical Entry and Exit Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

JPMorgan Chase & Co. Acquires 926,765 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat

Mar 21, 2026

Mar 20, 2026

CRNX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 20, 2026

Mar 19, 2026

Patterns Watch: What is the dividend yield of Crinetics Pharmaceuticals Inc2026 Retail & Weekly Top Gainers Alerts - baoquankhu1.vn

Mar 19, 2026

Mar 18, 2026

Crinetics Pharmaceuticals (NASDAQ:CRNX) Insider Stephen Betz Sells 10,612 Shares - MarketBeat

Mar 18, 2026

Mar 18, 2026

Crinetics Pharmaceuticals (NASDAQ:CRNX) CEO Sells $821,429.97 in Stock - MarketBeat

Mar 18, 2026

Mar 18, 2026

Crinetics Pharmaceuticals Insider Sold Shares Worth $821,513, According to a Recent SEC Filing - marketscreener.com

Mar 18, 2026

Mar 18, 2026

Crinetics Pharmaceuticals (CRNX) COO sells 9,911 shares for RSU taxes - Stock Titan

Mar 18, 2026

Mar 18, 2026

Crinetics (NASDAQ: CRNX) CSO sells shares to cover RSU tax - Stock Titan

Mar 18, 2026

Mar 18, 2026

Crinetics (CRNX) CEO discloses tax-related share sales under 10b5-1 plan - Stock Titan

Mar 18, 2026

Mar 18, 2026

CRNX (NASDAQ: CRNX) insider sells shares via 10b5-1 and option exercise - Stock Titan

Mar 18, 2026

Mar 18, 2026

Jim Cramer on Crinetics: “That’s a better spec than Aquestive” - MSN

Mar 18, 2026